Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
41 621 BGN
44 156 BGN
Current assets
80 878 BGN
75 705 BGN
Non-current liabilities
2 189 BGN
2 632 BGN
Current liabilities
15 309 BGN
15 644 BGN
Revenue
48 512 BGN
43 146 BGN
Profit (loss)
- BGN
- BGN
3 398 BGN
- BGN
- BGN
3 398 BGN
3 398 BGN
- BGN
- BGN
2 790 BGN
- BGN
2 790 BGN
2 790 BGN
- BGN
Other comprehensive income
- BGN
- BGN
18,000 BGN
18,000 BGN
- BGN
- BGN
18,000 BGN
- BGN
- BGN
24,000 BGN
24,000 BGN
24,000 BGN
- BGN
- BGN
Comprehensive income
- BGN
- BGN
3 416 BGN
18,000 BGN
- BGN
3 398 BGN
3 416 BGN
- BGN
- BGN
2 766 BGN
24,000 BGN
2 766 BGN
2 790 BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.